Evidence map›Paper›PMID 31781219›Full record

ArticleJournal of oncology2019

The Combination of

Tsung-Han Wu, Kun-Yun Yeh, Chen-Hsu Wang, Hang Wang, Tsung-Lin Li, Yi-Lin Chan, Chang-Jer Wu

Abstract read
In one paragraph

Article in Journal of oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Advancement ofChinese herbal medicines · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Cancer management and research · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Molecules (Basel, Switzerland) · 2022
    Article
  14. Article
  15. Study on the Mechanism of Radix Astragali against Renal Aging Based on Network Pharmacology.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  16. Review
  17. Article
  18. Mechanisms ofIntegrative cancer therapies
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tsung-Han WuDepartment of Food Science and Center of Excellence for the Oceans, National Taiwan Ocean University, Keelung 20224, Taiwan.ORCID https://orcid.org/0000-0001-8455-8009
Kun-Yun YehDivision of Hemato-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 20401, Taiwan.
Chen-Hsu WangDivision of Hemato-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 20401, Taiwan.
Hang WangInstitute of Biomedical Nutrition, Hung-Kuang University, Taichung 43302, Taiwan.
Tsung-Lin LiGenomics Research Center, Academia Sinica, Taipei 11574, Taiwan.
Yi-Lin ChanDepartment of Life Science, Chinese Culture University, Taipei 11114, Taiwan.ORCID https://orcid.org/0000-0002-4096-8476
Chang-Jer WuDepartment of Food Science and Center of Excellence for the Oceans, National Taiwan Ocean University, Keelung 20224, Taiwan.ORCID https://orcid.org/0000-0002-5079-5839

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung cancer and its related cachexia are the leading cause of cancer death in the world. In this study, we report the inhibitory effect of the combined therapy of

Identifiers

PMID31781219
PMCPMC6875282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.